Related Experiment Video
Updated: May 10, 2026

06:15
Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
Differences in alloimmune response between elderly and young mice
1Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana. bbook@iupui.edu
Transplantation Proceedings
|June 18, 2013
Summary
Older mice showed significantly reduced alloantibody responses to new antigens compared to younger mice. This suggests age-related immune differences that may impact transplant outcomes.
Area of Science:
- Immunology
- Transplantation Immunology
- Gerontology
Background:
- The aging population is increasing the upper age of renal transplant recipients.
- Age-dependent immune responsiveness to novel antigens requires further investigation.
- Understanding these age-related immune differences is crucial for optimizing transplant strategies.
Purpose of the Study:
- To investigate age-related differences in immune response to neoalloantigens using a mouse model.
- To compare alloantibody production in elderly versus young mice after immunization with foreign antigens.
Main Methods:
- Transgenic mice were immunized with splenocytes, and plasma samples were collected over two months.
- Alloantibody levels were measured using flow cytometric crossmatch and median fluorescence intensity.
- Elderly (42-103 weeks) and young (11-15 weeks) mice were compared.
Main Results:
- No significant difference in baseline alloantibody levels between elderly and young mice.
- Younger mice exhibited significantly higher alloantibody responses at both 1 month (52.9 vs 5.12) and 2 months (109.38 vs 21.97) post-immunization.
- These differences in alloantibody response were statistically significant (P < .0024 at 2 months).
Conclusions:
- Older mice demonstrated significantly decreased immune responses to new alloantigen stimulation compared to younger mice.
- This animal model can be utilized to study age-related immune refractoriness to antigen signaling.
- Clinical immunosuppression protocols may need adaptation for the aged population due to potentially diminished immune responses.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
